Company Filing History:
1 out of 17 
1 out of 2 
1 out of 832,718 Years Active: 2004-2007
Title: Agoritsa Varaklioto: Innovator in Hepatitis C Research
Introduction
Agoritsa Varaklioto is a notable inventor based in Athens, Greece. She has made significant contributions to the field of molecular biology, particularly in the study of hepatitis C virus (HCV). With a total of 2 patents, her work has implications for both research and therapeutic applications.
Latest Patents
Varaklioto's latest patents focus on nucleic acids and new polypeptides associated with the hepatitis C virus core gene products. The first patent discloses DNA encoding core+1 polypeptides of HCV, along with nucleotides encoding these polypeptides and methods for utilizing them. The second patent similarly addresses nucleic acids and polypeptides related to the HCV core gene products, emphasizing the potential for innovative treatments and diagnostic tools.
Career Highlights
Throughout her career, Agoritsa Varaklioto has worked with prestigious institutions such as the Institute Pasteur and the Hellenic Pasteur Institute. Her research has been pivotal in advancing our understanding of hepatitis C and developing new strategies for combating this viral infection.
Collaborations
Varaklioto has collaborated with esteemed colleagues, including Penelope Mavromara and Urania Georgopoulou. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Agoritsa Varaklioto's work exemplifies the intersection of innovation and healthcare, particularly in the fight against hepatitis C. Her patents and collaborations highlight her commitment to advancing scientific knowledge and improving patient outcomes.